SCHEMBL30912965

SCHEMBL30912965

O=C(Nc1ccccc1)c1nc2cc(Br)ccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 1/20 0.51
MMP2 P08253 3/20 0.51
MMP9 P14780 3/20 0.51
MMP8 P22894 3/20 0.51
MMP13 P45452 3/20 0.51
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
DGAT1 O75907 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
F12 P00748 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
TP53 P04637 2/20 0.44
POLB P06746 1/20 0.44
PTGFR P43088 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
COMT P21964 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29086858 1.00 EGLN1 (0.51) EGLN1MMP2MMP9MMP8MMP13
SCHEMBL29086790 0.91 MEN1 (0.52) EGLN1MMP2MMP9MMP8MMP13
SCHEMBL30642968 0.91 MEN1 (0.52) EGLN1MMP2MMP9MMP8MMP13
SCHEMBL29086759 0.84 TP53 (0.60) MMP2MMP9MMP8MMP13NPC1
SCHEMBL30912944 0.84 MTOR (0.49) NPC1RAB9ASMN1; SMN2LMNADGAT1
SCHEMBL30912925 0.84 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2LMNADGAT1
SCHEMBL30912931 0.84 TP53 (0.60) MMP2MMP9MMP8MMP13NPC1
SCHEMBL29086673 0.84 MTOR (0.49) NPC1RAB9ASMN1; SMN2LMNADGAT1
SCHEMBL4437426 0.83 MMP2 (0.58) MMP2MMP9MMP8MMP13NPC1
SCHEMBL29086780 0.83 KMT2A (0.58) EGLN1MMP2MMP9MMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024109642-A1 USE OF BENZOAZACYCLIC COMPOUND AS ALLOSTERIC MODULATOR OF β2-ADRENOCEPTOR 常州大学 2024-05-30 WO disclosed